D-penicillamine-induced autoimmunity: Relationship to macrophage activation

Chemical Research in Toxicology

Volumn 22, Issue 9, 2009, Pages 1526-1533

  Li, Jinze ^a   Uetrecht, Jack P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; INTERLEUKIN 1BETA; PENICILLAMINE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNITY; LUPUS ERYTHEMATOSUS; MACROPHAGE ACTIVATION; MALE; NATURAL KILLER CELL; NONHUMAN; RAT; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; GENE EXPRESSION PROFILING; KILLER CELLS, NATURAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; PENICILLAMINE; RATS; RNA, MESSENGER;

MURINAE; RATTUS NORVEGICUS;

EID: 70349310507     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx900128p     Document Type: Article

References (37)

1. Uetrecht, J. (2008) Idiosyncratic drug reactions: past, present, and future. Chem. Res. Toxicol. 21, 84-92. (Pubitemid 351219710)
2. Kavai, M., and Szegedi, G. (2007) Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus. Autoimmun. Rev. 6, 497-502. (Pubitemid 47069975)
3. Coleman, D. L. (1986) Regulation of macrophage phagocytosis. Eur. J. Clin. Microbiol. 5, 1-5.
4. Hart, S. P., Dransfield, I., and Rossi, A. G. (2008) Phagocytosis of apoptotic cells. Methods 44, 280-285.
5. Rosenthal, A. S. (1980) Regulation of the immune response - role of the macrophage. N. Engl. J. Med. 303, 1153-1156. (Pubitemid 11240489)
6. McCoy, C. E., and O'Neill, L. A. (2008) The role of toll-like receptors in macrophages. Front. Biosci. 13, 62-70.
7. Fadok, V. A., McDonald, P. P., Bratton, D. L., and Henson, P. M. (1998) Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem. Soc. Trans. 26, 653-656. (Pubitemid 29008142)
8. Gordon, S. (1998) The role of the macrophage in immune regulation. Res. Immunol. 149, 685-688.
9. Arceci, R. J. (2008) When T cells and macrophages do not talk: the hemophagocytic syndromes. Curr. Opin. Hematol. 15, 359-367.
10. Zhang, K., Biroschak, J., Glass, D. N., Thompson, S. D., Finkel, T., Passo, M. H., Binstadt, B. A., Filipovich, A., and Grom, A. A. (2008) Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum. 58, 2892-2896.
11. Tristano, A. G. (2008) Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Med. Sci. Monit. 14, RA27-36.
12. Pringe, A., Trail, L., Ruperto, N., Buoncompagni, A., Loy, A., Breda, L., Martini, A., and Ravelli, A. (2007) Macrophage activation syndrome in juvenile systemic lupus erythematosus: an underrecognized complication? Lupus 16, 587-592. (Pubitemid 47359993)
13. Donker, A. J., Venuto, R. C., Vladutiu, A. O., Brentjens, J. R., and Andres, G. A. (1984) Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin. Immunol. Immunopathol. 30, 142-155.
14. Masson, M. J., and Uetrecht, J. P. (2004) Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated. Chem. Res. Toxicol. 17, 82-94.
15. Binderup, L., Bramm, E., and Arrigoni-Martelli, E. (1980) D-penicillamine in vivo enhances lymphocyte DNA synthesis: role of macrophages. Scand. J. Immunol. 11, 23-28. (Pubitemid 10146390)
16. Binderup, L., Bramm, E., and Arrigoni-Martelli, E. (1978) D-penicillamine and macrophages: modulation of lymphocyte transformation by concanavalin A. Scand. J. Immunol. 7, 259-264. (Pubitemid 8321362)
17. Arrigoni-Martelli, E., and Binderup, L. (1981) D-penicillamine, lymphocytes, and macrophages: an account of experimental investigations in vivo. J. Rheumatol. Suppl. 7, 62-68. (Pubitemid 11108123)
18. Rhodes, J. (1996) Covalent chemical events in immune induction: fundamental and therapeutic aspects. Immunol. Today 17, 436-441.
19. Rhodes, J., Chen, H., Hall, S. R., Beesley, J. E., Jenkins, D. C., Collins, P., and Zheng, B. (1995) Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature 377, 71-75.
20. Uetrecht, J. (2005) Current trends in drug-induced autoimmunity. Autoimmun. Rev. 4, 309-314.
21. Li, J., Mannargudi, B. Uetrecht, J. (2009) Covalent binding of penicillamine to macrophages: implications for penicillamine-induced autoimmunity. Chem. Res. Toxicol. [Online early access], DOI: 10.1021/tx900087z, published online May 22, 2009.
22. Dobrovolskaia, M. A., and Vogel, S. N. (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4, 903-914.
23. Polfliet, M. M., Fabriek, B. O., Daniels, W. P., Dijkstra, C. D., and van den Berg, T. K. (2006) The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. Immunobiology 211, 419-425.
24. Behrens, E. M. (2008) Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell? Autoimmun. Rev. 7, 305-308.
25. Yeap, S. T., Sheen, J. M., Kuo, H. C., Hwang, K. P., Yang, K. D., and Yu, H. R. (2008) Macrophage activation syndrome as initial presentation of systemic lupus erythematosus. Pediatr. Neonatol. 49, 39-42.
26. van den Berg, T. K., Dopp, E. A., and Dijkstra, C. D. (2001) Rat macrophages: membrane glycoproteins in differentiation and function. Immunol. Rev. 184, 45-57. (Pubitemid 34123763)
27. Masson, M. J., Teranishi, M., Shenton, J. M., and Uetrecht, J. P. (2004) Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat. J. Immunot. 1, 79-93.
28. Smyth, M. J., Cretney, E., Kelly, J. M., Westwood, J. A., Street, S. E., Yagita, H., Takeda, K., van Dommelen, S. L., Degli-Esposti, M. A., and Hayakawa, Y. (2005) Activation of NK cell cytotoxicity. Mol. Immunol. 42, 501-510.
29. Di Santo, J. P. (2006) Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24, 257-286.
30. Ma, A., Koka, R., and Burkett, P. (2006) Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24, 657-679.
31. Pazmany, L. (2005) Do NK cells regulate human autoimmunity? Cytokine 32, 76-80.
32. Perricone, R., Perricone, C., De Carolis, C., and Shoenfeld, Y. (2008) NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun. Rev. 7, 384-390.
33. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
34. Butler, M., Carruthers, G., Harth, M., Freeman, D., Percy, J., and Rabenstein, D. (1982) Pharmacokinetics of reduced D-penicillamine in patients with rheumatoid arthritis. Arthritis Rheum. 25, 111-116. (Pubitemid 12215980)
35. Kulms, D., and Schwarz, T. (2006) NF-kappaB and cytokines. Vitam. Horm. 74, 283-300.
36. Rhodus, N. L., Cheng, B., Myers, S., Bowles, W., Ho, V., and Ondrey, F. (2005) A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin. Immunol. 114, 278-283. (Pubitemid 40267669)
37. Mise-Omata, S., Kuroda, E., Niikura, J., Yamashita, U., Obata, Y., and Doi, T. S. (2007) A proximal kappaB site in the IL-23 p19 promoter is responsible for RelA- and c-Rel-dependent transcription. J. Immunol. 179, 6596-6603.